CYTK Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $23,883,980.51

Cytokinetics Insider Trading History Chart

Cytokinetics Share Price & Price History

^$61.70

▼ -1.25 (-1.99%)

As of 03/20/2026 05:00 PM ET

Days: 30 | 90 | 365

Cytokinetics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/18/2026	Andrew Callos	EVP	Sell	1,930	$62.07	$119,795.10	78,185
3/17/2026	Andrew Callos	EVP	Sell	8,542	$62.15	$530,885.30	71,573
3/17/2026	Fady Ibraham Malik	EVP	Sell	12,033	$62.15	$747,850.95	153,902
3/17/2026	Robert I Blum	CEO	Sell	36,601	$62.15	$2,274,752.15	430,330
3/17/2026	Sung Lee	EVP	Sell	4,935	$62.15	$306,710.25	87,127
3/16/2026	Andrew Callos	EVP	Sell	1,709	$61.03	$104,300.27	46,149
3/9/2026	Andrew Callos	EVP	Sell	2,582	$60.72	$156,779.04	47,858
3/9/2026	Fady Ibraham Malik	EVP	Sell	2,907	$60.72	$176,513.04	138,629
3/9/2026	Robert I Blum	CEO	Sell	7,931	$60.72	$481,570.32	391,673
3/5/2026	Andrew Callos	EVP	Sell	26,000	$61.87	$1,608,620.00	50,440
2/5/2026	Andrew Callos	EVP	Sell	15,000	$61.93	$928,950.00	50,440
2/2/2026	Andrew Callos	EVP	Sell	886	$62.10	$55,020.60	50,440
1/5/2026	Andrew Callos	EVP	Sell	15,000	$60.28	$904,200.00	50,440
1/2/2026	Andrew Callos	EVP	Sell	1,798	$62.62	$112,590.76	50,440
12/29/2025	Andrew Callos	EVP	Sell	1,809	$62.44	$112,953.96	51,353
12/22/2025	Wendell Wierenga	Director	Sell	20,000	$66.14	$1,322,800.00	32,444
12/16/2025	Fady Ibraham Malik	EVP	Sell	2,200	$61.24	$134,728.00	138,552
12/8/2025	Andrew Callos	EVP	Sell	1,042	$65.96	$68,730.32	50,660
12/5/2025	Andrew Callos	EVP	Sell	52,486	$65.95	$3,461,451.70	50,660
12/2/2025	Fady Ibraham Malik	EVP	Sell	2,200	$63.89	$140,558.00	140,610
12/2/2025	John T Henderson	Director	Sell	8,750	$63.90	$559,125.00	74,578
12/1/2025	Edward M. Kaye	Director	Sell	28,064	$66.72	$1,872,430.08	9,977
12/1/2025	Robert Arthur Harrington	Director	Sell	2,150	$66.80	$143,620.00	18,542
11/19/2025	B. Lynne Parshall	Director	Sell	5,000	$64.73	$323,650.00	22,933
11/18/2025	Fady Ibraham Malik	EVP	Sell	2,200	$66.45	$146,190.00	140,610
11/11/2025	Edward M. Kaye	Director	Sell	5,175	$65.08	$336,789.00	9,977
11/4/2025	Fady Ibraham Malik	EVP	Sell	2,295	$59.55	$136,667.25	140,610
10/30/2025	Robert I Blum	CEO	Sell	5,000	$62.86	$314,300.00	358,108
10/27/2025	Wendell Wierenga	Director	Sell	4,375	$58.68	$256,725.00	32,444
10/21/2025	Fady Ibraham Malik	EVP	Sell	2,105	$58.22	$122,553.10	140,610
10/16/2025	Robert I Blum	CEO	Sell	5,000	$60.03	$300,150.00	363,108
10/7/2025	Fady Ibraham Malik	EVP	Sell	2,000	$60.56	$121,120.00	140,610
10/6/2025	Edward M. Kaye	Director	Sell	6,757	$60.00	$405,420.00	9,778
10/1/2025	Robert I Blum	CEO	Sell	5,000	$55.05	$275,250.00	368,108
9/30/2025	Edward M. Kaye	Director	Sell	6,695	$55.08	$368,760.60	16,535
9/23/2025	Fady Ibraham Malik	EVP	Sell	2,000	$49.28	$98,560.00	140,610
9/15/2025	Robert I Blum	CEO	Sell	5,000	$49.77	$248,850.00	373,108
9/9/2025	Fady Ibraham Malik	EVP	Sell	2,000	$51.29	$102,580.00	140,610
9/2/2025	Edward M. Kaye	Director	Sell	6,756	$50.00	$337,800.00	23,230
8/19/2025	Fady Ibraham Malik	EVP	Sell	2,000	$38.31	$76,620.00	140,610
8/5/2025	Fady Ibraham Malik	EVP	Sell	2,000	$36.34	$72,680.00	140,610
7/29/2025	Robert I Blum	CEO	Sell	5,000	$36.45	$182,250.00	388,108
7/22/2025	Fady Ibraham Malik	EVP	Sell	2,000	$37.47	$74,940.00	140,610
7/14/2025	Robert I Blum	CEO	Sell	5,000	$38.15	$190,750.00	393,108
7/8/2025	Fady Ibraham Malik	EVP	Sell	2,000	$33.76	$67,520.00	140,610
6/16/2025	Robert I Blum	CEO	Sell	5,000	$33.80	$169,000.00	403,108
6/5/2025	Andrew Callos	EVP	Sell	8,659	$32.04	$277,434.36	52,028
6/5/2025	Edward M. Kaye	Director	Sell	3,636	$32.10	$116,715.60	29,658
6/2/2025	Robert I Blum	CEO	Sell	5,000	$31.22	$156,100.00	408,108
5/15/2025	Muna Bhanji	Director	Sell	1,454	$29.73	$43,227.42	23,510
5/5/2025	Andrew Callos	EVP	Sell	4,002	$36.68	$146,793.36	60,687
4/29/2025	Robert I Blum	CEO	Sell	5,000	$40.96	$204,800.00	417,629
4/22/2025	Fady Ibraham Malik	EVP	Sell	2,000	$38.11	$76,220.00	140,255
4/21/2025	Wendall Wierenga	Director	Sell	20,000	$38.46	$769,200.00	24,848
4/15/2025	John T Henderson	Director	Sell	3,190	$38.66	$123,325.40	66,348
4/10/2025	Robert I Blum	CEO	Sell	5,000	$36.77	$183,850.00	422,629
4/7/2025	Andrew Callos	EVP	Sell	2,886	$35.78	$103,261.08	64,689
4/3/2025	Robert Arthur Harrington	Director	Sell	450	$39.43	$17,743.50	14,658
3/31/2025	Robert I Blum	CEO	Sell	15,000	$40.75	$611,250.00	427,629
3/17/2025	Andrew Callos	EVP	Sell	2,775	$44.38	$123,154.50	34,888
3/17/2025	Robert I Blum	CEO	Sell	12,648	$44.38	$561,318.24	326,533
3/14/2025	Andrew Callos	EVP	Sell	100	$45.00	$4,500.00	37,663
3/6/2025	Andrew Callos	EVP	Sell	3,341	$43.27	$144,565.07	64,434
3/6/2025	Robert I Blum	CEO	Sell	16,970	$43.44	$737,176.80	364,181
2/18/2025	Fady Ibraham Malik	EVP	Sell	2,000	$45.98	$91,960.00	116,071
2/4/2025	Fady Ibraham Malik	EVP	Sell	2,000	$48.06	$96,120.00	116,071
1/21/2025	Fady Ibraham Malik	EVP	Sell	2,000	$45.92	$91,840.00	116,071
1/7/2025	Fady Ibraham Malik	EVP	Sell	2,000	$49.32	$98,640.00	116,071
12/16/2024	Wendall Wierenga	Director	Sell	742	$48.61	$36,068.62	24,559
12/11/2024	John T Henderson	Director	Sell	1,780	$50.42	$89,747.60	38,461
12/10/2024	Fady Ibraham Malik	EVP	Sell	7,300	$50.64	$369,672.00	116,071
12/2/2024	Robert I Blum	CEO	Sell	5,000	$50.76	$253,800.00	397,678
11/26/2024	Fady Ibraham Malik	EVP	Sell	7,300	$50.16	$366,168.00	111,878
11/18/2024	Robert I Blum	CEO	Sell	5,000	$50.55	$252,750.00	397,456
11/12/2024	Fady Ibraham Malik	EVP	Sell	6,342	$58.48	$370,880.16	113,878
11/1/2024	Robert I Blum	CEO	Sell	5,000	$51.63	$258,150.00	397,456
10/30/2024	Fady Ibraham Malik	EVP	Sell	7,300	$51.91	$378,943.00	114,920
10/28/2024	Wendall Wierenga	Director	Sell	4,452	$52.25	$232,617.00	24,559
10/15/2024	Fady Ibraham Malik	EVP	Sell	7,300	$54.19	$395,587.00	116,920
10/9/2024	Robert I Blum	CEO	Sell	5,000	$55.61	$278,050.00	397,456
10/1/2024	Fady Ibraham Malik	EVP	Sell	7,300	$52.10	$380,330.00	118,920
9/30/2024	Robert I Blum	CEO	Sell	5,000	$52.14	$260,700.00	397,456
9/3/2024	Fady Ibraham Malik	EVP	Sell	7,384	$57.01	$420,961.84	122,920
9/3/2024	Robert I Blum	CEO	Sell	5,000	$57.03	$285,150.00	397,456
8/12/2024	B. Lynne Parshall	Director	Sell	5,000	$55.20	$276,000.00	20,600
8/12/2024	Robert I Blum	CEO	Sell	11,500	$55.17	$634,455.00	399,412
8/6/2024	Fady Ibraham Malik	EVP	Sell	7,300	$53.71	$392,083.00	121,704
7/30/2024	Robert I Blum	CEO	Sell	11,500	$59.49	$684,135.00	399,412
7/29/2024	B. Lynne Parshall	Director	Sell	5,000	$59.84	$299,200.00	20,600
7/23/2024	Fady Ibraham Malik	EVP	Sell	7,300	$57.02	$416,246.00	129,004
7/15/2024	B. Lynne Parshall	Director	Sell	5,000	$55.82	$279,100.00	20,600
7/10/2024	Robert I Blum	CEO	Sell	11,500	$54.29	$624,335.00	399,412
7/9/2024	Fady Ibraham Malik	EVP	Sell	7,300	$55.90	$408,070.00	131,004
7/5/2024	Robert Arthur Harrington	Director	Sell	253	$54.61	$13,816.33	15,516
7/1/2024	B. Lynne Parshall	Director	Sell	5,000	$54.22	$271,100.00	20,600
7/1/2024	Robert I Blum	CEO	Sell	11,500	$54.05	$621,575.00	405,145
6/25/2024	Fady Ibraham Malik	EVP	Sell	7,300	$53.72	$392,156.00	133,004
6/17/2024	B. Lynne Parshall	Director	Sell	5,000	$52.55	$262,750.00	20,600
6/17/2024	Robert I Blum	CEO	Sell	22,500	$52.60	$1,183,500.00	416,645
6/11/2024	Fady Ibraham Malik	EVP	Sell	7,788	$53.04	$413,075.52	135,004
6/10/2024	Muna Bhanji	Director	Sell	2,000	$52.07	$104,140.00	17,631
6/4/2024	Robert I Blum	CEO	Sell	22,500	$48.85	$1,099,125.00	439,145
6/3/2024	Robert Arthur Harrington	Director	Sell	1,580	$48.64	$76,851.20	15,541
6/3/2024	Robert Wong	CAO	Sell	13,011	$48.88	$635,977.68	16,653
5/7/2024	Fady Ibraham Malik	EVP	Sell	15,547	$65.11	$1,012,265.17	137,056
4/25/2024	John T Henderson	Director	Sell	10,562	$64.54	$681,671.48	32,070
4/9/2024	Fady Ibraham Malik	EVP	Sell	32,605	$74.31	$2,422,877.55	138,567
3/5/2024	Fady Ibraham Malik	EVP	Sell	32,604	$67.56	$2,202,726.24	138,973
2/14/2024	John T Henderson	Director	Sell	5,000	$76.48	$382,400.00	42,632
2/6/2024	Fady Ibraham Malik	EVP	Sell	32,605	$79.30	$2,585,576.50	142,973
1/31/2024	Robert I Blum	CEO	Sell	12,500	$79.57	$994,625.00	441,797
1/19/2024	Robert I Blum	CEO	Sell	12,500	$81.42	$1,017,750.00	441,797
1/12/2024	John T Henderson	Director	Sell	5,000	$85.14	$425,700.00	42,632
1/4/2024	Fady Ibraham Malik	EVP	Sell	15,678	$86.98	$1,363,672.44	146,973
1/2/2024	Robert I Blum	CEO	Sell	12,500	$85.08	$1,063,500.00	441,797
12/27/2023	Wendall Wierenga	Director	Sell	10,000	$73.60	$736,000.00	18,653
11/15/2023	Robert I Blum	CEO	Sell	12,500	$34.57	$432,125.00	441,417
11/9/2023	Fady Ibraham Malik	EVP	Sell	2,500	$35.40	$88,500.00	150,664
10/30/2023	Robert I Blum	CEO	Sell	12,500	$32.17	$402,125.00	441,417
10/16/2023	Robert I Blum	CEO	Sell	12,500	$33.70	$421,250.00	441,417
10/12/2023	Fady Ibraham Malik	EVP	Sell	2,500	$35.89	$89,725.00	153,164
10/6/2023	Robert I Blum	CEO	Sell	12,500	$30.00	$375,000.00	441,417
9/14/2023	Fady Ibraham Malik	EVP	Sell	2,500	$34.86	$87,150.00	155,664
9/13/2023	Robert I Blum	CEO	Sell	12,500	$34.90	$436,250.00	441,417
8/25/2023	Robert I Blum	CEO	Sell	12,500	$33.99	$424,875.00	441,417
8/21/2023	Wendall Wierenga	Director	Sell	6,020	$32.02	$192,760.40	18,205
8/11/2023	Robert I Blum	CEO	Sell	12,500	$32.37	$404,625.00	441,417
8/1/2023	Robert I Blum	CEO	Sell	12,500	$32.63	$407,875.00	441,417
7/13/2023	Fady Ibraham Malik	EVP	Sell	2,500	$35.37	$88,425.00	160,664
7/13/2023	Robert I Blum	CEO	Sell	12,500	$35.28	$441,000.00	441,417
7/7/2023	Muna Bhanji	Director	Sell	2,000	$34.12	$68,240.00	14,031
7/3/2023	Robert I Blum	CEO	Sell	12,500	$32.60	$407,500.00	441,417
6/12/2023	Robert I Blum	CEO	Sell	12,500	$37.06	$463,250.00	441,417
6/8/2023	Fady Ibraham Malik	EVP	Sell	2,500	$38.07	$95,175.00	163,164
5/31/2023	Robert I Blum	CEO	Sell	12,500	$37.67	$470,875.00	441,058
5/16/2023	Robert I Blum	CEO	Sell	12,500	$37.41	$467,625.00	441,058
5/15/2023	John T Henderson	Director	Sell	4,166	$37.77	$157,349.82	25,420
5/11/2023	Fady Ibraham Malik	EVP	Sell	1,787	$39.50	$70,586.50	165,396
5/3/2023	Fady Ibraham Malik	EVP	Sell	7,000	$40.00	$280,000.00	167,183
4/28/2023	Robert I Blum	CEO	Sell	12,500	$37.68	$471,000.00	441,058
4/14/2023	Robert I Blum	CEO	Sell	12,500	$35.61	$445,125.00	441,058
4/13/2023	Fady Ibraham Malik	EVP	Sell	4,000	$34.21	$136,840.00	167,183
3/28/2023	Robert I Blum	CEO	Sell	12,500	$35.05	$438,125.00	441,058

SEC Filings (Institutional Ownership Changes) for Cytokinetics (NASDAQ:CYTK)

Institutional Buying and Selling by Quarter

Cytokinetics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/20/2026	Hsbc Holdings PLC	3,696	$0.24M	0.0%	-7.7%	0.003%
3/17/2026	Rockefeller Capital Management L.P.	641	$41K	0.0%	+842.6%	0.001%
3/9/2026	Corient Private Wealth LLC	7,044	$0.45M	0.0%	+46.4%	0.006%
2/26/2026	Seven Fleet Capital Management LP	10,335	$0.66M	0.5%	N/A	0.008%
2/26/2026	Alpine Global Management LLC	6,000	$0.38M	0.1%	N/A	0.005%
2/24/2026	Pacer Advisors Inc.	27,783	$1.77M	0.0%	+76.5%	0.023%
2/19/2026	T. Rowe Price Investment Management Inc.	17,716,372	$1.13B	0.7%	-7.1%	14.491%
2/19/2026	Invesco Ltd.	204,878	$13.02M	0.0%	+30.3%	0.168%
2/19/2026	Corient Private Wealth LLC	30,184	$1.92M	0.0%	+527.1%	0.025%
2/18/2026	Creek Drive Management Group LLC	10,000	$0.64M	0.5%	N/A	0.008%
2/18/2026	Vident Advisory LLC	16,455	$1.05M	0.0%	+1.4%	0.013%
2/18/2026	State of Tennessee Department of Treasury	37,506	$2.37M	0.0%	-22.6%	0.031%
2/18/2026	XTX Topco Ltd	90,579	$5.76M	0.2%	+2,170.2%	0.074%
2/18/2026	VARCOV Co.	6,013	$0.38M	0.2%	N/A	0.005%
2/18/2026	Virtus Investment Advisers LLC	4,247	$0.27M	0.1%	+23.9%	0.003%
2/18/2026	Sphera Funds Management LTD.	91,717	$5.83M	1.1%	-43.2%	0.075%
2/18/2026	Polymer Capital Management US LLC	8,014	$0.51M	0.1%	N/A	0.007%
2/18/2026	Readystate Asset Management LP	122,711	$7.80M	0.3%	-13.9%	0.100%
2/18/2026	Millennium Management LLC	225,456	$14.33M	0.0%	-34.2%	0.184%
2/18/2026	Man Group plc	11,587	$0.74M	0.0%	N/A	0.009%
2/18/2026	Inspire Investing LLC	7,330	$0.47M	0.0%	-10.5%	0.006%
2/18/2026	Janus Henderson Group PLC	256,212	$16.28M	0.0%	+416.9%	0.210%
2/18/2026	Engineers Gate Manager LP	111,544	$7.09M	0.1%	N/A	0.091%
2/18/2026	Catalio Capital Management LP	258,381	$16.42M	3.0%	-42.8%	0.211%
2/18/2026	Cinctive Capital Management LP	6,562	$0.42M	0.0%	-93.8%	0.005%
2/18/2026	ACT Capital Management LLC	64,500	$4.10M	3.3%	N/A	0.053%
2/17/2026	Guggenheim Capital LLC	31,322	$1.99M	0.0%	+1.4%	0.026%
2/17/2026	Logos Global Management LP	300,000	$19.06M	1.2%	N/A	0.245%
2/17/2026	ADAR1 Capital Management LLC	540,166	$34.32M	2.5%	+4.1%	0.442%
2/17/2026	Pennington Partners & CO. LLC	3,278	$0.21M	0.1%	N/A	0.003%
2/17/2026	AQR Capital Management LLC	236,925	$14.78M	0.0%	-53.8%	0.194%
2/17/2026	Abel Hall LLC	3,666	$0.23M	0.1%	N/A	0.003%
2/17/2026	Cetera Investment Advisers	14,269	$0.91M	0.0%	-16.7%	0.012%
2/17/2026	EFG International AG	53,265	$3.39M	0.1%	N/A	0.044%
2/17/2026	Amundi	6,773	$0.43M	0.0%	N/A	0.006%
2/17/2026	Price T Rowe Associates Inc. MD	1,930,119	$122.64M	0.0%	-18.5%	1.579%
2/17/2026	T. Rowe Price Investment Management Inc.	9,390,404	$596.67M	0.6%	-50.8%	7.681%
2/17/2026	Rock Springs Capital Management LP	35,853	$2.28M	0.1%	N/A	0.029%
2/17/2026	Osaic Holdings Inc.	52,436	$3.33M	0.0%	-4.2%	0.043%
2/17/2026	Harvey Capital Management Inc.	46,810	$2.97M	0.6%	+119.5%	0.038%
2/17/2026	Granahan Investment Management LLC	82,121	$5.22M	0.2%	+53.4%	0.067%
2/17/2026	Kemnay Advisory Services Inc.	428	$27K	0.0%	N/A	0.000%
2/17/2026	State of Wisconsin Investment Board	68,633	$4.36M	0.0%	-8.4%	0.056%
2/17/2026	Captrust Financial Advisors	4,649	$0.30M	0.0%	N/A	0.004%
2/17/2026	Fred Alger Management LLC	10,563	$0.67M	0.0%	-80.7%	0.009%
2/17/2026	&PARTNERS	3,636	$0.23M	0.0%	N/A	0.003%
2/17/2026	Melqart Asset Management UK Ltd	622,898	$39.58M	3.9%	-20.5%	0.509%
2/17/2026	ExodusPoint Capital Management LP	343,144	$21.80M	0.2%	N/A	0.281%
2/17/2026	Persistent Asset Partners Ltd	3,214	$0.20M	0.1%	N/A	0.003%
2/17/2026	Cynosure Group LLC	7,354	$0.47M	0.0%	-29.1%	0.006%
2/16/2026	Thornburg Investment Management Inc.	82,398	$5.24M	0.1%	-2.7%	0.067%
2/16/2026	Vanguard Personalized Indexing Management LLC	20,725	$1.32M	0.0%	+14.6%	0.017%
2/16/2026	MML Investors Services LLC	4,842	$0.31M	0.0%	N/A	0.004%
2/16/2026	Nicholas Investment Partners LP	70,240	$4.46M	0.3%	+13.1%	0.057%
2/16/2026	First Turn Management LLC	325,668	$20.69M	2.4%	+27.8%	0.266%
2/16/2026	Frazier Life Sciences Management L.P.	934,642	$59.39M	1.6%	+5.0%	0.764%
2/16/2026	Kennedy Capital Management LLC	13,183	$0.84M	0.0%	+1.2%	0.011%
2/16/2026	Eventide Asset Management LLC	479,611	$30.47M	0.5%	+181.9%	0.392%
2/16/2026	Brown Advisory Inc.	731,154	$46.46M	0.1%	-19.8%	0.598%
2/16/2026	Aigen Investment Management LP	5,568	$0.35M	0.1%	N/A	0.005%
2/13/2026	Kestra Advisory Services LLC	451	$29K	0.0%	N/A	0.000%
2/13/2026	Marshall Wace LLP	337,031	$21.42M	0.0%	+88.3%	0.276%
2/13/2026	The Manufacturers Life Insurance Company	190,807	$11.96M	0.0%	-0.6%	0.156%
2/13/2026	Quinn Opportunity Partners LLC	38,082	$2.42M	0.1%	-86.1%	0.031%
2/13/2026	CANADA LIFE ASSURANCE Co	66,203	$4.21M	0.0%	-15.7%	0.054%
2/13/2026	Segall Bryant & Hamill LLC	189,513	$12.04M	0.2%	+4.7%	0.155%
2/13/2026	Affinity Asset Advisors LLC	800,000	$50.83M	2.9%	+128.6%	0.654%
2/13/2026	Stifel Financial Corp	47,971	$3.05M	0.0%	+7.5%	0.039%
2/13/2026	Hudson Bay Capital Management LP	175,350	$11.14M	0.0%	-3.7%	0.143%
2/13/2026	Commerce Bank	3,967	$0.25M	0.0%	N/A	0.003%
2/13/2026	Smartleaf Asset Management LLC	1,458	$89K	0.0%	+218.3%	0.001%
2/13/2026	Bridgefront Capital LLC	9,484	$0.60M	0.2%	-8.9%	0.008%
2/13/2026	Exome Asset Management LLC	124,749	$7.93M	3.8%	-12.4%	0.102%
2/13/2026	Rafferty Asset Management LLC	98,541	$6.26M	0.0%	-5.3%	0.081%
2/13/2026	First Trust Advisors LP	127,524	$8.10M	0.0%	N/A	0.104%
2/13/2026	Headlands Technologies LLC	4,199	$0.27M	0.0%	N/A	0.003%
2/13/2026	Charles Schwab Investment Management Inc.	1,383,437	$87.90M	0.0%	+0.7%	1.132%
2/13/2026	Police & Firemen s Retirement System of New Jersey	31,502	$2M	0.0%	-3.3%	0.026%
2/13/2026	State Street Corp	5,825,295	$370.14M	0.0%	+3.7%	4.765%
2/13/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	235,049	$14.94M	0.0%	-1.4%	0.192%
2/13/2026	Wells Fargo & Company MN	161,556	$10.27M	0.0%	-92.2%	0.132%
2/13/2026	Rhenman & Partners Asset Management AB	44,375	$2.82M	0.3%	-82.6%	0.036%
2/13/2026	Quadrant Capital Group LLC	14,696	$0.93M	0.0%	+58.9%	0.012%
2/12/2026	HRT Financial LP	23,376	$1.49M	0.0%	N/A	0.019%
2/12/2026	Brooklyn Investment Group	10,566	$0.65M	0.0%	+18.3%	0.009%
2/12/2026	Orion Porfolio Solutions LLC	11,633	$0.74M	0.0%	+3.6%	0.010%
2/12/2026	MetLife Investment Management LLC	121,910	$7.75M	0.0%	-4.5%	0.100%
2/12/2026	GSK plc	340,434	$21.63M	2.7%	N/A	0.278%
2/12/2026	Cibc World Markets Corp	7,729	$0.49M	0.0%	N/A	0.006%
2/12/2026	Commonwealth Equity Services LLC	4,845	$0.31M	0.0%	-5.6%	0.004%
2/12/2026	Renaissance Technologies LLC	172,067	$10.93M	0.0%	-40.7%	0.141%
2/12/2026	Dimensional Fund Advisors LP	53,929	$3.43M	0.0%	+5.2%	0.044%
2/12/2026	Jasper Ridge Partners L.P.	5,500	$0.35M	0.0%	N/A	0.004%
2/12/2026	Federated Hermes Inc.	483,668	$30.73M	0.1%	+1,775.1%	0.396%
2/12/2026	Ensign Peak Advisors Inc	7,296	$0.46M	0.0%	-64.4%	0.006%
2/12/2026	AlphaCentric Advisors LLC	5,311	$0.34M	0.3%	N/A	0.004%
2/12/2026	Marex Group plc	8,002	$0.51M	0.0%	N/A	0.007%
2/12/2026	Rosalind Advisors Inc.	195,045	$12.39M	4.6%	-51.2%	0.160%
2/12/2026	Skandinaviska Enskilda Banken AB publ	88,684	$5.64M	0.0%	-40.9%	0.073%
2/12/2026	New York State Common Retirement Fund	46,175	$2.93M	0.0%	-3.6%	0.038%

Data available starting January 2016

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure. The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; CK-586, a small molecule cardiac myosin inhibitor, that is in Phase I clinical trial; and aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy. Cytokinetics, Incorporated has a strategic alliance with Ji Xing Pharmaceuticals Limited. The company was incorporated in 1997 and is headquartered in South San Francisco, California.

Today's Range

Now: $61.70

$61.02

$63.98

50 Day Range

MA: $63.77

$60.00

$70.10

52 Week Range

Now: $61.70

$29.31

$70.98

Volume

3,212,479 shs

Average Volume

2,153,220 shs

Market Capitalization

$7.60 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.56

Who are the company insiders with the largest holdings of Cytokinetics?: Cytokinetics' top insider shareholders include:
Robert I Blum (CEO)
Fady Ibraham Malik (EVP)
Sung Lee (EVP)
Andrew Callos (EVP)
John T Henderson (Director)
Wendell Wierenga (Director)
Edward M Md Kaye (Director)
Wendall Wierenga (Director)
Muna Bhanji (Director)
B Lynne Parshall (Director)
Robert Arthur Harrington (Director)
Robert Wong (CAO)
Learn More about top insider investors at Cytokinetics.
Who are the major institutional investors of Cytokinetics?: Cytokinetics' top institutional shareholders include:
T. Rowe Price Investment Management Inc. — 14.49%
Vanguard Group Inc. — 9.85%
T. Rowe Price Investment Management Inc. — 7.68%
State Street Corp — 4.76%
Geode Capital Management LLC — 2.50%
Price T Rowe Associates Inc. MD — 1.58%
Learn More about top institutional investors of Cytokinetics stock.
Which major investors are selling Cytokinetics stock?: During the previous quarter, CYTK stock was sold by these institutional investors:
T. Rowe Price Investment Management Inc.
Wells Fargo & Company MN
T. Rowe Price Investment Management Inc.
UBS Group AG
Aberdeen Group plc
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.
Price T Rowe Associates Inc. MD
Pictet Asset Management Holding SA
Within the previous year, company insiders that have sold Cytokinetics company stock include:
Robert I Blum (CEO)
Fady Ibraham Malik (EVP)
Sung Lee (EVP)
Andrew Callos (EVP)
John T Henderson (Director)
Wendell Wierenga (Director)
Edward M Md Kaye (Director)
Wendall Wierenga (Director)
Muna Bhanji (Director)
B Lynne Parshall (Director)
Robert Arthur Harrington (Director)
Learn More investors selling Cytokinetics stock.
Which major investors are buying Cytokinetics stock?: In the previous quarter, CYTK stock was purchased by institutional investors including:
Norges Bank
Northwestern Mutual Wealth Management Co.
Federated Hermes Inc.
Affinity Asset Advisors LLC
ExodusPoint Capital Management LP
GSK plc
BNP Paribas Financial Markets
Eventide Asset Management LLC